New Delhi, Feb 2 (IANS) The Union Budget’s plan to establish daycare cancer centres in every district over the next three years is a timely initiative, experts said on Sunday.
Cancer incidence in India is rising, with cases expected to increase by 27.7 per cent from 2015 to 2025.
According to the ‘National Cancer Registry Programme Report’ 2020, one in nine people is likely to develop cancer in their lifetime.
The Budget move “aims to improve access to cancer treatment and support, particularly in remote areas, bridging a critical gap in healthcare services,” said Ashok Varma, Partner, Grant Thornton Bharat.
The Government will facilitate the setting up of daycare cancer centres and 200 such centres will be established in 2025-26.
Moreover, the Budget announced 36 life-saving drugs and medicines (mainly for cancer and rare diseases) to be added to the list of medicines that are fully exempt from basic customs duty (BCD). Another six life-saving medicines are to be added to the list, which would attract concessional customs duty of 5 per cent.
Garima Malhotra, Associate Partner, Healthcare and Lifesciences at Praxis Global Alliance, said that the expansion of medical education with 10,000 additional seats and the plan to add 75,000 seats over the next five years will address the shortage of healthcare professionals.
“The establishment of daycare cancer centres in all district hospitals is a critical move towards enhancing accessibility to specialised treatment. These measures, along with continued investment in public health infrastructure, will improve healthcare access and affordability, fostering a healthier India,” she mentioned.
The Government’s push for improved access to life-saving medicines through the addition of 36 drugs to the exempted list and enhanced support for rare disease treatments is a welcome move.
The rationalisation of customs tariffs for industrial goods, including incentives for domestic pharmaceutical manufacturing, will further boost India’s position as the ‘Pharmacy of the World.’
The emphasis on R&D with a Rs 20,000 crore investment in private-sector-led innovation will also accelerate drug discovery and biotech advancements, said experts.
–IANS
na/uk
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
